- Home
- PAAS vs HOLX Comparison
PAAS vs HOLX Comparison
Compare PAAS & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAAS
- HOLX
- Stock Information
- Founded
- PAAS 1994
- HOLX 1985
- Country
- PAAS Canada
- HOLX United States
- Employees
- PAAS N/A
- HOLX N/A
- Industry
- PAAS
- HOLX Medical Electronics
- Sector
- PAAS
- HOLX Health Care
- Exchange
- PAAS Nasdaq
- HOLX Nasdaq
- Market Cap
- PAAS 15.4B
- HOLX 15.0B
- IPO Year
- PAAS 1995
- HOLX 1990
- Fundamental
- Price
- PAAS $39.58
- HOLX $67.13
- Analyst Decision
- PAAS Buy
- HOLX Buy
- Analyst Count
- PAAS 4
- HOLX 14
- Target Price
- PAAS $33.25
- HOLX $78.92
- AVG Volume (30 Days)
- PAAS 7.1M
- HOLX 2.3M
- Earning Date
- PAAS 11-04-2025
- HOLX 11-03-2025
- Dividend Yield
- PAAS 1.07%
- HOLX N/A
- EPS Growth
- PAAS N/A
- HOLX N/A
- EPS
- PAAS 1.44
- HOLX 2.41
- Revenue
- PAAS $3,116,300,000.00
- HOLX $4,038,900,000.00
- Revenue This Year
- PAAS $15.83
- HOLX $3.37
- Revenue Next Year
- PAAS $8.12
- HOLX $4.51
- P/E Ratio
- PAAS $27.33
- HOLX $28.05
- Revenue Growth
- PAAS 21.09
- HOLX 1.29
- 52 Week Low
- PAAS $19.80
- HOLX $51.90
- 52 Week High
- PAAS $40.42
- HOLX $84.39
- Technical
- Relative Strength Index (RSI)
- PAAS 68.81
- HOLX 50.77
- Support Level
- PAAS $37.56
- HOLX $66.94
- Resistance Level
- PAAS $40.42
- HOLX $69.12
- Average True Range (ATR)
- PAAS 1.29
- HOLX 1.82
- MACD
- PAAS 0.07
- HOLX 0.08
- Stochastic Oscillator
- PAAS 85.30
- HOLX 61.91
About PAAS Pan American Silver Corp.
Pan American Silver Corp is a mining company principally engaged in the operation and development of, and exploration for, silver and gold-producing properties and assets. The company's principal products are silver and gold, although it also produces and sells zinc, lead, and copper. Its operating mines comprise La Colorada, Dolores, Huaron, Morococha, Shahuindo, La Arena, Timmins West, Bell Creek, Manantial Espejo, and San Vicente mines.
About HOLX Hologic Inc.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.